Surial was identical (8 months in both groups) in the intermediate-II and high-risk categories.
在中II和更高风险类别中，生存期相同，二组都为8个月。
Surial was significantly longer in the younger group (40 months) than in the older group (23 months).
生存期年轻患者为40个月，年老患者为23个月，年轻患者明显延长。
Our data demonstrate that long-term surial is acceptable in heart transplant recipients with preoperatiely diagnosed DM and DRCs.
我们的研究数据表明，对被诊断为伴有并发症的糖尿病患者进行心脏移植，他们的长期存活率是可以接受的。
应用推荐